活性RhoA在紫杉醇诱导肾癌周期阻滞中的作用及机制研究
[Abstract]:Background: renal cell carcinoma (RCC) is the most common type of malignant tumor of renal parenchyma, accounting for about 2% of adult cancer diseases. At present, surgery is the main treatment of renal cell carcinoma, and there is no uniform standard for postoperative adjuvant treatment. Paclitaxel (Taxol) is a new antitubule agent, which can promote the aggregation of microtubule (MT) protein and stabilize MT, thus inhibit the dynamic recombination of microtubule network, inhibit the proliferation of tumor cells, and be used in adjuvant chemotherapy after radical surgery for progressive renal cell carcinoma. It can benefit some patients. It was found that RhoA expression was significantly increased in many kinds of tumors, which could regulate tumor growth, proliferation, invasion and metastasis. However, the relationship between active RhoA (GTP-RhoA) and cytoskeleton structure and the regulation of cell cycle (cell cycle) have not been reported. Objective: to investigate the effect of MT changes induced by Taxol on the expression of cell cycle and active RhoA. To further explore the MT changes in the distribution and location of RhoA protein. The expression of active RhoA and the changes of cell cycle were observed by destroying the depolymerization of MT, and the changes of MT and cell cycle were observed by inhibiting the activity of RhoA,. To explore the significance of active RhoA in Taxol induced renal cancer cell cytoskeleton block cell cycle process. Methods: Taxol treated renal cancer cell line OS-RC-2 was used as the study object, MT and RhoA protein were stained with immunofluorescence, and the changes of MT and RhoA protein distribution and location were observed by confocal microscope. The expression of RhoA protein and GTP-RhoA protein were measured by Western-blot, and the cell cycle was determined by flow cytometry. The experimental data were expressed as'X 卤SD 'and analyzed with SPSS version 13.0. The results showed that the expression of GTP-RhoA in OS-RC-2 cell cycle arrest induced by taxol in G 2 / M phase was significantly up-regulated by LSD and SNK test (P 0.05). The results showed that the MT polymerization of OS-RC-2 cells induced by Taxol was positively time-dependent and formed a specific bunchy structure, which was wrapped around the nucleus. 3. The active RhoA was redistributed with the polymerization of MT and depolymerization, but remained relatively consistent with the position of MT. 4. The depolymerization agent Col of MT destroyed the specific structure of MT induced by Taxol and reversed the G 2 / M phase arrest of cells. After down-regulation of RhoA activity by down-regulation of active RhoA expression, the cell cycle arrest induced by Taxol was partially reversed, but there was no significant effect on the structure of polymerized MT. Conclusion MT polymerization induced by 1: Taxol could induce the formation of specific fascicular rings and increase the activity of RhoA in OS-RC-2 cells. This process plays an important role in cell cycle arrest and inhibition of tumor proliferation in the treatment of renal cell carcinoma with Taxol. On the contrary, the active RhoA had no obvious effect on the MT that had been polymerized. Significance: by studying the relationship between MT, activity RhoA and cell cycle in OS-RC-2 cells, the mechanism and important role of active RhoA in the regulation of RCC cell cycle by MT were elucidated. Rho A has potential value in regulating the efficacy of Taxol in the treatment of renal cell carcinoma.
【学位授予单位】:宁波大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.11
【相似文献】
相关期刊论文 前8条
1 吕刚;姚鑫;;小分子干扰RNA介导RhoA沉默优化骨髓间充质干细胞的培养[J];中国组织工程研究与临床康复;2010年45期
2 邹佳;李长清;;RhoA信号通路调控与中枢神经系统损伤和修复[J];神经损伤与功能重建;2008年04期
3 宋富强;陈炜;王嘉丽;张俊磊;胡晓梅;;RhoA突变体的构建及稳定表达[J];免疫学杂志;2010年10期
4 赵戈;刘卫辉;王涛;王兴;夏宁;杨平;寇明文;张宁;陶开山;;小分子干扰RNA介导的RhoA沉默优化胎肝干细胞培养[J];中国组织工程研究;2012年10期
5 王雪;王维莉;任雨;庄海慧;王萍;;RhoA介导的细胞骨架在肿瘤发生发展中的作用[J];中国细胞生物学学报;2014年02期
6 陈三杰;朱益华;;急性高眼压大鼠视网膜RhoA的分布及表达[J];国际眼科杂志;2009年07期
7 周鹰;朱洪;彭江龙;;螨性哮喘患者支气管肺泡灌洗液中RhoA的表达水平[J];南方医科大学学报;2009年07期
8 马骥;赵庆丽;钟翠萍;刘文超;薛妍;;RhoA对食管癌Eca-109细胞VEGF表达的调控作用[J];临床肿瘤学杂志;2014年06期
相关会议论文 前2条
1 邓菁;冯恩光;马晟;张彦;李洪林;柳红;蒋华良;缪丽燕;李剑;;第一代RhoA小分子抑制剂的发现、及其舒张血管的机制和应用研究[A];2011年全国药物化学学术会议——药物的源头创新论文摘要集[C];2011年
2 周峻;金岩;董绍忠;李媛;;RhoA和蛋白激酶A对舌癌细胞的迁移影响[A];中华口腔医学会第七届全国口腔病理学术会议论文摘要汇编[C];2006年
相关博士学位论文 前4条
1 李璐;肾癌中MMP-7的表达及生物信息学分析[D];郑州大学;2017年
2 黎晖;Fbxw7通过RhoA信号通路调控胃癌细胞凋亡、生长抑制及上皮间质转化的分子机制研究[D];重庆医科大学;2016年
3 钟琳;新生未成熟大鼠少突胶质前体细胞缺氧缺糖模型中RhoA和细胞骨架蛋白的研究[D];四川大学;2007年
4 陈国忠;骨髓间充质干细胞调控肝星状细胞增殖、凋亡和RhoA表达的研究[D];广西医科大学;2010年
相关硕士学位论文 前6条
1 樊晓骁;活性RhoA在紫杉醇诱导肾癌周期阻滞中的作用及机制研究[D];宁波大学;2017年
2 王玺;50例原发性肾癌患者中医用药规律的临床研究[D];辽宁中医药大学;2017年
3 虎晓军;肾细胞癌的CT影像学表现与病理学类型的相关性研究[D];宁夏医科大学;2017年
4 陈烈;RhoA在颅内海绵状血管瘤中的表达及意义[D];中南大学;2014年
5 苏思标;骨髓间充质干细胞调控肝星状细胞RhoA、p27的表达[D];广西医科大学;2010年
6 于家兴;评价R.E.N.A.L、PADUA、C-index评分系统对T_1期肾癌患者保留肾单位手术的应用价值[D];宁夏医科大学;2017年
,本文编号:2204785
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2204785.html